Home LiteratureArticle Details
PMID: 8876170 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

A eukaryotic enzyme that can disjoin dead-end covalent complexes between DNA and type I topoisomerases.

Yang SW, Burgin AB, Huizenga BN, Robertson CA, Yao KC, Nash HA

Abstract

The covalent joining of topoisomerases to DNA is normally a transient step in the reaction cycle of these important enzymes. However, under a variety of circumstances, the covalent complex is converted to a long-lived or dead-end product that can result in chromosome breakage and cell death. We have discovered and partially purified an enzyme that specifically cleaves the chemical bond that joins the active site tyrosine of topoisomerases to the 3' end of DNA. The reaction products made by the purified enzyme on a variety of model substrates indicate that the enzyme cleanly hydrolyzes the tyrosine-DNA phosphodiester linkage, thereby liberating a DNA terminated with a 3' phosphate. The wide distribution of this phosphodiesterase in eukaryotes and its specificity for tyrosine linked to the 3' end but not the 5' end of DNA suggest that it plays a role in the repair of DNA trapped in complexes involving eukaryotic topoisomerase I.

MeSH Terms
Binding Sites DNA/chemistry,metabolism DNA Repair DNA Topoisomerases, Type I/chemistry,metabolism Kinetics Models, Chemical Molecular Weight Oligodeoxyribonucleotides/chemical synthesis,chemistry,metabolism Phosphoric Diester Hydrolases/isolation & purification,metabolism Saccharomyces cerevisiae/enzymology Substrate Specificity Tyrosine
Chemicals
Oligodeoxyribonucleotides Tyrosine DNA Phosphoric Diester Hydrolases DNA Topoisomerases, Type I
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Yang S W
Laboratory of Molecular Biology, National Institute of Mental Health, Bethesda, MD 20892-4034, USA.
Burgin A B
Huizenga B N
Robertson C A
Yao K C
Nash H A
References (25)
25 references, click to expand
  1. A novel suicide substrate for DNA topoisomerases and site-specific recombinases.
    Nucleic Acids Res. 1995 Aug 11;23(15):2973-9 PMID: 7659520
  2. 5'phosphorylation of DNA in mammalian cells: identification of a polymin P-precipitable polynucleotide kinase.
    J Cell Biochem. 1995 May;58(1):115-31 PMID: 7642718
  3. Human DNA topoisomerase I-mediated cleavages stimulated by ultraviolet light-induced DNA damage.
    J Biol Chem. 1996 Mar 22;271(12):6978-86 PMID: 8636127
  4. DNA topoisomerases.
    Annu Rev Biochem. 1996;65:635-92 PMID: 8811192
  5. Preclinical and clinical development of camptothecins.
    Adv Pharmacol. 1994;29B:51-72 PMID: 8996601
  6. Mechanisms of topoisomerase I inhibition by anticancer drugs.
    Adv Pharmacol. 1994;29B:73-92 PMID: 8996602
  7. Viral integration and excision: structure of the lambda att sites.
    Science. 1977 Sep 16;197(4309):1147-60 PMID: 331474
  8. DNA structural features that lead to strand breakage by eukaryotic type-I topoisomerase.
    Cold Spring Harb Symp Quant Biol. 1984;49:435-42 PMID: 6099251
  9. Chromatin 3'-phosphatase/5'-OH kinase cannot transfer phosphate from 3' to 5' across a strand nick in DNA.
    Nucleic Acids Res. 1986 Oct 24;14(20):8103-10 PMID: 3022244
  10. Site-specific recombination intermediates trapped with suicide substrates.
    Cell. 1987 Aug 28;50(5):779-88 PMID: 3040260
  11. DNA topoisomerase-targeting antitumor drugs can be studied in yeast.
    Proc Natl Acad Sci U S A. 1988 Oct;85(20):7501-5 PMID: 2845409
  12. Minimal DNA duplex requirements for topoisomerase I-mediated cleavage in vitro.
    J Biol Chem. 1990 Jul 25;265(21):12529-35 PMID: 2165067
  13. Isolation of yeast nuclei.
    Methods Enzymol. 1991;194:735-49 PMID: 2005821
  14. Symmetry in the mechanism of bacteriophage lambda integrative recombination.
    Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9642-6 PMID: 1409677
  15. Ligation of synthetic activated DNA substrates by site-specific recombinases and topoisomerase I.
    J Biol Chem. 1993 Feb 15;268(5):3683-9 PMID: 8381436
  16. The covalent eukaryotic topoisomerase I-DNA intermediate catalyzes pH-dependent hydrolysis and alcoholysis.
    J Biol Chem. 1994 Apr 15;269(15):11367-73 PMID: 8157668
  17. Mammalian topoisomerase I has base mismatch nicking activity.
    J Biol Chem. 1994 Jun 3;269(22):15498-504 PMID: 8195193
  18. DNA topoisomerases: essential enzymes and lethal targets.
    Annu Rev Pharmacol Toxicol. 1994;34:191-218 PMID: 8042851
  19. Specific cleavage of model recombination and repair intermediates by the yeast Rad1-Rad10 DNA endonuclease.
    Science. 1994 Sep 30;265(5181):2082-5 PMID: 8091230
  20. Cellular determinants of sensitivity and resistance to DNA topoisomerase inhibitors.
    Cancer Invest. 1994;12(5):530-42 PMID: 7922710
  21. Architectural elements in nucleoprotein complexes: interchangeability of specific and non-specific DNA binding proteins.
    EMBO J. 1994 Oct 3;13(19):4536-48 PMID: 7925295
  22. Cellular regulation of mammalian DNA topoisomerases.
    Adv Pharmacol. 1994;29A:167-89 PMID: 7826857
  23. Topoisomerase I-related parameters and camptothecin activity in the colon carcinoma cell lines from the National Cancer Institute anticancer screen.
    Cancer Res. 1995 May 15;55(10):2116-21 PMID: 7743511
  24. SCT1 mutants suppress the camptothecin sensitivity of yeast cells expressing wild-type DNA topoisomerase I.
    Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6299-303 PMID: 7603986
  25. Topoisomerase poisons: harnessing the dark side of enzyme mechanism.
    J Biol Chem. 1995 Sep 15;270(37):21429-32 PMID: 7665550
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1996-10-15
Pages
11534-9
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC38092
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]